Reduce drug prices by eliminating PBM rebates

  • The Hill | by: Robert M. Goldberg |
  • 2017-02-15
N/A by N/A is licensed under N/A N/A
Why are pharmacy benefit management companies -the businesses that put together the drug benefits for most Americans the latest target of drug price critics? PBMs generated nearly $130 billion in rebates – essentially cash that drug companies pay PBMs to reduce the cost of their products. 
 
That’s nearly 30 percent of the $349 billion in gross revenues the drug industry generates each year. On top of that PBMs charge the sickest patients an average of 40 percent of the list price of medicines.  So why not use these rebates to reduce drug costs. 
 
The PBMs claim that $130 billion in rebates do lower drug prices for consumers.

In fact, they pass the rebates directly to insurance companies and some businesses that contract with the PBM. In turn, the health plans use their cut for anything they want.  For example, a lawsuit against Anthem claims that the insurer used billions in rebate dollars to buy back its stock in preparation for its failed merger with Cigna.

 
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

FDA Hears Concerns About The Unregulated CBD Market

FDA Hears Concerns About The Unregulated CBD Market

What most speakers agreed on: the need for federal CBD oversight for production quality, more testing and research and be...  Read more

Peter Pitts discusses New York lawsuit against Opioid manufacturer on i24NEWS
  • i24NEWS
  • 2019-04-01

Peter Pitts discusses New York lawsuit against Opioid manufacturer on i24NEWS

CMPI President Peter J. Pitts discusses the Opioid lawsuits...  Read more

HHS's ideas for rearranging Medicare would raise costs for seniors

HHS's ideas for rearranging Medicare would raise costs for seniors

This new arrangement would particularly hurt 25 percent of traditional Medicare enrollees who purchase supplemental "Medi...  Read more

DRUGWONKS BLOG